A critical look at the evidence for the oxidation of LDL in atherogenesis

Atherosclerosis

Volumn 131, Issue SUPPL., 1997, Pages

  Steinberg, Daniel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; CELL INTERACTION; CONFERENCE PAPER; ENDOTHELIUM CELL; HUMAN; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; VITAMIN INTAKE;

EID: 0030798039     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)06115-7     Document Type: Conference Paper

References (7)

1. Steinberg D, Witztum JL. Lipoproteins and atherogenesis. Current concepts. J Am Med Assoc 1990;264:3047.
2. Steinberg D. Role of oxidized LDL and antioxidants in atherosclerosis. Adv Exp Med Biol 1995;369:39.
3. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781.
4. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029.
5. Walldius G, Erikson U, Olsson A, Bergstrand L, Hadell K, Johansson J, et al. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol 1994;74:875.
6. Hennekens C, Buring J, Manson J, Stampfer M, Rosner B, Cook N, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145.
7. Omenn G, Goodman G, Thornquist M, Balmes J, Cullen M, Glass A, et al. Effects of a combination of beta and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150.